Attention Deficit Hyperactivity Disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type
Conditions
Interventions
Intervention 1: Intervention group: Melissa officinalis syrup of Ehyateb Daru Tabiat company with a dose of 0.2 cc per kilogram of weight in two divided doses recipients. Intervention 2: Control group
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
7 Years to 12 Years
Inclusion criteria
Inclusion criteria: The patient with DSM V ADHD criteria, Absence of other systemic or psychiatric disorders, IQ in the normal range at least three months have passed since their standard drug treatment, Completion of the informed consent form by the parent
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Revised Children's Anxiety Scale. Timepoint: in 3 and 6 weeks. Method of measurement: The amount of change in the revised children's anxiety scale questionnaire.;Attention deficit hyperactivity disorder scoring scale questionnaires. Timepoint: in 3 and 6 weeks. Method of measurement: The amount of change in attention deficit hyperactivity disorder scoring scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Revised Children's Manifest Anxiety Scale score. Timepoint: week 3 and 6. Method of measurement: The amount of change in the anxiety score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Moharari
Mashhad University of Medical Sciences
Outcome results
None listed